Craig-Hallum Maintains Buy on BioLife Solns, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Matt Hewitt maintains a Buy rating on BioLife Solutions (NASDAQ:BLFS) and raises the price target from $23 to $30.
August 12, 2024 | 5:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum analyst Matt Hewitt maintains a Buy rating on BioLife Solutions and raises the price target from $23 to $30.
The raised price target from $23 to $30 by a reputable analyst is likely to positively impact investor sentiment and drive short-term price appreciation for BioLife Solutions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100